| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.44B | +25.6% |
| Cost of Revenue | $472.0M | +29.1% |
| R&D Expense | $463.3M | +12.5% |
| SG&A Expense | $535.8M | +3.0% |
| Operating Income | $427.2M | +113.1% |
| Pre-tax Income | $507.3M | +89.3% |
| Income Tax | $114.2M | +28.3% |
| Net Income | $393.1M | +119.7% |
| EPS (Basic) | $0.80 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.37B | +53.0% |
| Short-term Investments | $552.0M | +13.8% |
| Accounts Receivable | $3.33B | +16.0% |
| Current Assets | $5.34B | +23.7% |
| Total Assets | $6.11B | +25.0% |
| Current Liabilities | $2.87B | +14.4% |
| Total Liabilities | $3.16B | +16.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $739.5M | +23.6% |
| Capital Expenditures | $98.2M | +110.0% |
| Investing Cash Flow | -$157.5M | -46.4% |
| Financing Cash Flow | -$107.6M | +82.8% |
| Free Cash Flow | $641.2M | +16.3% |
| +116.2% |
| EPS (Diluted) | $0.78 | +116.7% |
| Stockholders' Equity |
| $2.95B |
| +36.3% |